Skip to main content
. 2017 Oct 7;37(5):459–465. doi: 10.1097/INF.0000000000001808

FIGURE 1.

FIGURE 1.

Design of study A4001031. S1, Stage 1: Intensive PK/dose finding (4–12 weeks): Minimum of 12 (Cohort 1) and 10 children (in each of Cohorts 2–4) to complete Stage 1 before entering Stage 2. S2, Stage 2: Safety/Efficacy: Following the minimum numbers being reached for Stage 1, all new patients then directly entered Stage 2.